AstraZeneca and Ionis both saw their stocks take a hit on 9 July following the ATTR-CM trial failure.
Wearable sensors remain largely underused, despite their utility in improving data collection and regulatory compliance.
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...
Combine proprietary data, human expertise, and purpose-built AI to uncover insights and accelerate better business decisions.
Discover our solutions
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Clinical trial experts cite trust and regulatory uncertainty as AI barriers
Kidney disease risk higher after Covid infection than after influenza infection
CinnaGen Enters EU Market with EMA Approval for Zandoriah®
Oncology trial systems debut at SCOPE 2026 as AI adoption accelerates